Document
PGR2021-00003, No. 2 Petition - Petition for Post Grant Review of US Patent No 10,596,276 (P.T.A.B. Oct. 2, 2020)
Cite Document
PGR2021-00003, No. 2 Petition - Petition for Post Grant Review of US Patent No 10,596,276 (P.T.A.B. Oct. 2, 2020)
+ More Snippets
Document
PGR2021-00003, No. 11 Refund Request - Petitioners Request for Refund of Post Institution Fees (P.T.A.B. Apr. 30, 2021)
Cite Document
PGR2021-00003, No. 11 Refund Request - Petitioners Request for Refund of Post Institution Fees (P.T.A.B. Apr. 30, 2021)
+ More Snippets
Document
PGR2021-00003, No. 8 Exhibit List - Petitioner Evergreen Theragnostics, Inc���s Updated List of Exhibits (P.T.A.B. Feb. 22, 2021)
Cite Document
PGR2021-00003, No. 8 Exhibit List - Petitioner Evergreen Theragnostics, Inc���s Updated List of Exhibits (P.T.A.B. Feb. 22, 2021)
+ More Snippets
Document
PGR2021-00003, No. 6 Preliminary Response - Patent Owners Preliminary Response (P.T.A.B. Jan. 19, 2021)
Cite Document
PGR2021-00003, No. 6 Preliminary Response - Patent Owners Preliminary Response (P.T.A.B. Jan. 19, 2021)
+ More Snippets
Document
PGR2021-00003, No. 5 Power of Attorney - Patent Owners Power of Attorney (P.T.A.B. Oct. 23, 2020)
Cite Document
PGR2021-00003, No. 5 Power of Attorney - Patent Owners Power of Attorney (P.T.A.B. Oct. 23, 2020)
+ More Snippets
Document
PGR2021-00003, No. 4 Mandatory Notice - Patent Owners Mandatory Notice (P.T.A.B. Oct. 23, 2020)
Cite Document
PGR2021-00003, No. 4 Mandatory Notice - Patent Owners Mandatory Notice (P.T.A.B. Oct. 23, 2020)
+ More Snippets
Document
PGR2021-00003, No. 1 Power of Attorney - Power of Attorney (P.T.A.B. Oct. 2, 2020)
Cite Document
PGR2021-00003, No. 1 Power of Attorney - Power of Attorney (P.T.A.B. Oct. 2, 2020)
+ More Snippets
Document
PGR2021-00003, No. 1037-38 Exhibit - Declaration of Paul E Dietze, PhD, Esq (P.T.A.B. Feb. 22, 2021)
Cite Document
PGR2021-00003, No. 1037-38 Exhibit - Declaration of Paul E Dietze, PhD, Esq (P.T.A.B. Feb. 22, 2021)
+ More Snippets
Document
PGR2021-00003, No. 1037 Exhibit - Declaration of Paul E Dietze, PhD, Esq (P.T.A.B. Feb. 22, 2021)
Cite Document
PGR2021-00003, No. 1037 Exhibit - Declaration of Paul E Dietze, PhD, Esq (P.T.A.B. Feb. 22, 2021)
+ More Snippets
Document
PGR2021-00003, No. 2001-32 Exhibit - Price et al, ¿¿¿Role of Supplementary Material in Biomedical Journal Articles Surveys of Authors, Reviewers and Readers,¿¿¿ BMJ Open 2018 20188e02175...
Cite Document
PGR2021-00003, No. 2001-32 Exhibit - Price et al, ¿¿¿Role of Supplementary Material in Biomedical Journal Articles Surveys of Authors, Reviewers and Readers,¿¿¿ BMJ Open 2018 20188e021753 doi101136bmj
+ More Snippets
Document
PGR2021-00003, No. 2004-35 Exhibit - Liu et al, ¿¿¿Ascorbic Acid Useful as a Buffer Agent and Radiolytic Stabilizer for Metalloradiopharmaceuticals,¿¿¿ Bioconjugate Chem, 2003, 14, 1052 1056 ¿...
Cite Document
PGR2021-00003, No. 2004-35 Exhibit - Liu et al, ¿¿¿Ascorbic Acid Useful as a Buffer Agent and Radiolytic Stabilizer for Metalloradiopharmaceuticals,¿¿¿ Bioconjugate Chem, 2003, 14, 1052 1056 ¿¿¿Liu 20
+ More Snippets
Document
PGR2021-00003, No. 2003-34 Exhibit - Chen et al, US Patent Pub No 20070269375A1 ¿¿¿Chen 375¿¿¿ (P.T.A.B. Jan. 19, 2021)
Cite Document
PGR2021-00003, No. 2003-34 Exhibit - Chen et al, US Patent Pub No 20070269375A1 ¿¿¿Chen 375¿¿¿ (P.T.A.B. Jan. 19, 2021)
+ More Snippets
Document
PGR2021-00003, No. 2005-36 Exhibit - Printouts from the New England Journal of Medicine website ¿¿¿NEJM Authors Center¿¿¿App¿¿¿x 1 Publication Process App¿¿¿x 2 What to Expect App¿¿¿x 3 ...
Cite Document
PGR2021-00003, No. 2005-36 Exhibit - Printouts from the New England Journal of Medicine website ¿¿¿NEJM Authors Center¿¿¿App¿¿¿x 1 Publication Process App¿¿¿x 2 What to Expect App¿¿¿x 3 New Manu
+ More Snippets
Document
PGR2021-00003, No. 2006-37 Exhibit - Supplementary Appendix to Strosberg J, El Haddad G, Wolin E, et al ¿¿¿Phase 3 trial of 177Lu Dotatate for midgut neuroendocrine tumors,¿¿¿ New England...
Cite Document
PGR2021-00003, No. 2006-37 Exhibit - Supplementary Appendix to Strosberg J, El Haddad G, Wolin E, et al ¿¿¿Phase 3 trial of 177Lu Dotatate for midgut neuroendocrine tumors,¿¿¿ New England J Med 201737
+ More Snippets
Document
PGR2021-00003, No. 2002-33 Exhibit - Pop and Salzberg, ¿¿¿Use and Mis Use of Supplementary Material in Scientific Publications,¿¿¿ BMC Bioinformatics 2015 16237 ¿¿¿Pop Salzberg¿¿¿ (P.T.A.B...
Cite Document
PGR2021-00003, No. 2002-33 Exhibit - Pop and Salzberg, ¿¿¿Use and Mis Use of Supplementary Material in Scientific Publications,¿¿¿ BMC Bioinformatics 2015 16237 ¿¿¿Pop Salzberg¿¿¿ (P.T.A.B. Jan. 19,
+ More Snippets